Interferon (IFN) treatment inhibited the replication of vesicular stomatitis virus (VSV) in human GM2767 and mouse JLSV-11 cells. The replication of this virus in either human Although the antiviral actions of interferons (IFNs) have been studied extensively, the detailed mechanism by which IFN inhibits the replication of a virus remains unclear (13, 28) . It is apparent that IFN can prevent virus replication by interfering with various steps in viral life cycles, for example, viral entry, viral macromolecular synthesis, and viral morphogenesis. Which, if any, of these impairments is the major one depends primarily on the virus in question. The particular host cell can also contribute to these effects.
Interferon (IFN) treatment inhibited the replication of vesicular stomatitis virus (VSV) in human GM2767 and mouse JLSV-11 cells. The replication of this virus in either human RD-114 or mouse A402 cells was insensitive to IFN treatment. We analyzed various steps in the VSV life cycle as they occurred under different conditions of EFN treatment to identify the point(s) at which IFN was exerting its inhibitory effect. IFN treatment led to strong inhibition of viral protein synthesis and accumulation of viral RNA in both lines of IFN-sensitive cells. No such effect was observed in the IFN-resistant cells. Using a temperature-sensitive mutant (tsG41) and wild-type VSV that were not undergoing protein synthesis, we determined that the major site of action of IFN against VSV replication in JLSV-1l and GM2767 cells was at the level of primary viral transcription. The accumulation of primary viral transcripts was strongly inhibited in these cells by IFN treatment. This effect was not a consequence of any effect of IFN on virus entry and uncoating. Thus, it appears that IFN exerts a direct effect on the VSV transcriptional process in GM2767 and JLSV-11 cells.
Although the antiviral actions of interferons (IFNs) have been studied extensively, the detailed mechanism by which IFN inhibits the replication of a virus remains unclear (13, 28) . It is apparent that IFN can prevent virus replication by interfering with various steps in viral life cycles, for example, viral entry, viral macromolecular synthesis, and viral morphogenesis. Which, if any, of these impairments is the major one depends primarily on the virus in question. The particular host cell can also contribute to these effects.
The actions of IFNs are mediated by the products of cellular genes whose expression is affected by IFN treatment. The specific roles of these gene products in the cellular response to IFN are poorly understood. The possibility exists that the replication of a family of viruses with similar replicative strategies may be affected by a product of the same IFN-inducible gene. Only one such IFN-inducible gene has been identified, the Mx gene product of mice, which specifically inhibits influenza virus replication (33) .
Vesicular stomatitis virus (VSV) is the prototype rhabdovirus whose replication is inhibited by IFN in many cells. The IFN-inducible gene product(s) responsible for the inhibition of VSV replication has not been identified. In most cases the major or exclusive site of action of IFN against VSV is at the level of viral RNA and protein synthesis, although defects in viral entry and morphogenesis have been demonstrated in some cell lines (1, 3, 5, 14-20, 24, 32, 34-36, 38) . Since VSV protein and RNA synthesis are interdependent, a defect in either process could be manifested as inhibition of both (2) .
Earlier attempts to identify the primary site of action of IFN against VSV have produced conflicting results. While some investigators concluded that the primary site of IFN action against VSV is at the level of primary transcription (15) (16) (17) , others concluded that it is at the level of viral protein synthesis (1, 3, 24, 32) . It was also suggested that the mechanism may be different in different cell lines (34) . These early studies were done with impure IFN preparations, since pure IFN was not available at that time. Since VSV cDNA clones were also unavailable, the methods of measuring viral RNA synthesis were imprecise. These measurements required the use of inhibitors of cellular RNA synthesis such as actinomycin D. Recently, Samuel and his colleagues have reinvestigated the mechanism of inhibition of VSV replication by IFN in human U amnion cells (18-20, 35, 36) . They used pure IFN preparations and better methods of quantitating VSV RNA levels. They did not observe any effect of IFN-aA on early or late stages of VSV replication. Inhibition of viral protein synthesis in the absence of any effect of IFN on primary viral transcription was observed. They concluded that IFN-aA treatment of these cells leads to a defect in the cellular translational machinery. This effect may be specific for IFN-a, since IFN--y treatment of the same cells reduces virus yield about 100-fold without pronounced inhibition of viral protein synthesis.
In contrast to these findings, we report here that in IFN-xA-treated human GM2767 fibroblasts and in IFN-ot/-treated mouse JLSV-11 cells VSV primary transcription was strongly inhibited. Binding was assayed by infecting monolayer cultures with 35S-VSV at an MOI of 10. In each case an equal number of IFN-treated and untreated cells were infected. After adsorption for 1 h at 37°C the monolayers were washed three times with 10 mM HEPES (N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic acid, pH 7.2)-150 mM NaCl (HEPES-saline) and lysed in HEPES-saline containing 0.5% sodium dodecyl sulfate. The radioactivity in each lysate was determined with a liquid scintillation spectrometer. Approximately 10% of the input radioactivity was bound under these conditions. Virus internalization was determined by binding the labeled virons as described above. After removal of the inoculum and washing with HEPES-saline, fresh medium was added. The cells were incubated at 37°C for 1.5 h. Medium was removed, and the monolayers were washed twice with HEPES-saline. Any virus remaining on the cell surface was removed by incubation with 0.25% trypsin-0.25% EDTA (7 min at room temperature). Trypsinization was stopped by the addition of HEPES-saline containing 10% serum. The cells were harvested by centrifugation and washed twice with HEPES-saline plus 10% serum. The pellet was then solubilized with HEPES-saline containing 0.5% sodium dodecyl sulfate, and the radioactivity was determined by liquid scintillation counting.
Uncoating of VSV was analyzed by infecting control and IFN-treated cell cultures with 35S-VSV at an MOI of 25 to increase the amount of cell-associated radioactivity. At this MOI IFN pretreatment still inhibited VSV replication by at least 104-fold (unpublished observations). At different times after infection cells were harvested and homogenized. The extracts were layered onto sucrose gradients, and nucleocapsids and virions were separated by centrifugation (18) . The gradients were fractionated, and the radioactivity in the virion and nucleocapsid peaks was determined. The relative radioactivity in the nucleocapsid versus virion peak at 2 h postinfection was used as an index of uncoating.
RESULTS
Effects of IFN on VSV production. The effect of IFN treatment on infectious VSV production is shown in Fig. 1 . Pairs of human and mouse cells were used for this analysis. VSV protein synthesis in IFN-treated cells. Our goal was to determine the point(s) in the VSV life cycle at which IFN was exerting its inhibitory effects. With the previously described cell lines, a step-by-step analysis of events in the VSV life cycle was carried out.
The rate of VSV protein synthesis as a function of IFN treatment was analyzed ( Fig. 2 and 3 ). Cells were pretreated with the indicated doses of IFN and challenged with VSV. analyzed by polyacrylamide gel electrophoresis. IFN treatment led to a strong inhibition of VSV protein synthesis in both sensitive cell lines JLSV-11 ( Fig. 2) and GM2767 (Fig.  3) . No such inhibition was observed in the resistant mouse cell line A402 (Fig. 2) , while a slight inhibition was observed in RD-114 cells at 100 U of IFN per ml (Fig. 3) thesis with tsG41 at the nonpermissive temperature (39.5°C). Under these conditions viral mRNAs are transcribed, using the input virion RNA (vRNA) as a template. Since replication of the tsG41 genome does not occur at this temperature (10, 37) , viral RNA and protein syntheses are not amplified and are restricted to that derived from input virions (primary transcription and translation). This virus behaved similarly to WT VSV in its IFN sensitivity (Table 1) Fig. 4 . In GM2767 cells G protein synthesis was inhibited by more than 99%, while in RD-114 cells the degree of inhibition was only about 25%. Similarly, IFN treatment inhibited G protein synthesis by about 80% in JLSV-11 cells, whereas no inhibition was observed in the A402 line.
Primary VSV transcription. It was important to determine whether the observed inhibition of primary translation in the IFN-sensitive cells was due to a direct effect of IFN on the synthesis of viral proteins or reflected an effect of IFN on primary viral transcription. Viral RNA synthesis was restricted to primary mRNA transcription in two ways: by using tsG41 at the nonpermissive temperature and by using WT VSV in the presence of 100 ,uM anisomycin (which inhibited protein synthesis by more than 95%; data not shown). The second method exploits the fact that replication of the VSV genome (and hence amplified RNA and protein synthesis) is dependent on ongoing protein synthesis, while primary mRNA transcription is not. The effect of various doses of IFN on the accumulation of primary VSV transcripts is illustrated in Fig. 5 . GM2767 and RD-114 cells were treated with the indicated doses of IFN-aA prior to challenge with WT VSV in the presence of 100 ,uM anisomycin. Total cytoplasmic RNA was prepared at 3 h postinfection and used for RNA dot blot analysis. The total VSV-specific RNA content of these cells was analyzed with a 32P-labeled cDNA probe that contained sequences complementary to all five virally encoded mRNAs. IFN treatment of GM2767 cells inhibited the accumulation of primary VSV transcripts in a dose-dependent fashion. The accumulation of these transcripts in RD-114 cells was unaffected by IFN treatment.
To determine whether the observed inhibition of primary transcription had any selectivity for any particular VSV mRNA, Northern analysis was performed. This analysis also allowed us to determine whether the decreased steady-state levels of primary transcripts observed in the IFN-sensitive cells was a consequence of degradation of the vRNA in the IFN-treated cells. RNA was extracted from GM2767 cells treated with various doses of IFN-oaA and infected with WT VSV in the presence of 100 ,uM anisomycin. The RNA was electrophoresed through a denaturing gel, transferred to nitrocellulose, and hybridized with the labeled VSV cDNA probe. In this gel system five VSV-related RNA species were observed: the vRNA, L mRNA, G mRNA, N mRNA, and NS/M mRNAs (which comigrate in this gel system). The levels of all VSV-related mRNAs were decreased in a dose-dependent manner by IFN treatment (Fig. 6) . The level of the vRNA (which was contributed by input virus) remained relatively unchanged even at the highest IFN dose tested (200 U/ml). This suggests that the inhibition of primary transcription in IFN-treated cells was not a result of degradation of the vRNA which served as the template.
In some of our Northern analyses (such as that shown in Fig. 6 ), we detected an RNA species that hybridized with the viral probe and whose level did not appear to diminish after IFN treatment. Several lines of evidence suggest that this RNA is probably a cellular rRNA: its length (about 5,000 nucleotides), its presence in uninfected cells, and its presence in the nonpolyadenylated fraction of RNA that had been subjected to oligo(dT)-cellulose chromatography (data not shown). This conclusion is also supported by recent evidence demonstrating sequence homology between VSV and rRNA (21) .
Treatment of RD-114 cells with doses of IFN-oA up to 200 U/ml did not appreciably decrease the level of any primary VSV transcript. With the ts mutant (tsG41) of VSV (at the restrictive temperature) used to analyze primary transcripts in GM2767 and RD-114 cells, the results were similar to those obtained with the WT virus (data not shown). Figure 7 shows the results of a Northern blot analysis of primary VSV transcripts in the two mouse cell lines, JLSV- 11 and A402. This blot shows the results with WT VSV plus 100 jxM anisomycin (lanes 1 and 2) and tsG41 at 39.5°C (lanes 3 and 4). As in the human G2767 cells, IFN treatment of JLSV-11 cells led to a reduction in the steady-state levels of 1 2 3 4 5 6 7 To quantitate the relative levels of the various VSVrelated RNAs in control and IFN-treated cells, the autoradiograms of the Northern blots were scanned with a densitometer ( Table 2 Table 3 . The lack of any significant effect of IFN on any event in the VSV life cycle occurring prior to primary transcription supports our hypothesis that IFN has a direct effect on this process.
DISCUSSION
In the studies reported here we attempted to identify the step(s) of the replication cycle of VSV that is sensitive to IFN-mediated inhibition. We used IFN-sensitive human and mouse cell lines for analyzing viral entry, uncoating, primary transcription, primary translation, total viral RNA and protein synthesis, and production of infectious progeny virions. Our data indicate that viral primary transcription was impaired in IFN-treated cells. All of the experiments described here were done with human IFN-aA or mouse IFN-oc/I. We also observed that VSV primary transcription was inhibited in IFN-y-treated GM2767 cells. A 500-U/ml amount of IFN--y, which reduced VSV yields about 103-fold, decreased the level of VSV primary transcripts by about 80% without affecting the level of VSV genomic RNA (unpublished observations).
VSV primary transcription was measured by two independent methods: WT VSV was used in the presence of an inhibitor of protein synthesis, and tsG41 was used at the nonpermissive temperature. Each method has its shortcomings. Inhibitors of protein synthesis may affect synthesis of VSV mRNAs directly and thus influence the results by an unknown degree. They can also prevent synthesis of IFNinducible cellular proteins which are necessary for the anti-VSV effects. On the other hand, tsG41 can only be used at a nonphysiological temperature, at which the cellular agent responsible for the anti-VSV effect could be inactive. Since this VSV mutant is to some degree leaky ( (5) . However, Masters and Samuel concluded that such is not the case in human amnion U cells. They postulated that a defect in the translational machinery was the cause for poor translation of VSV mRNA in IFN-treated U cells (19) . Results 1, 3, 24, 32 ). It is difficult to compare our results with most of the early investigations because of the inherent differences in the reagents and techniques used for measuring VSV transcription. The above reservation does not apply to the studies by , who used techniques and reagents similar to ours. Our studies do differ in that we used two independent methods of measuring VSV primary transcription. We also measured transcription of all five VSV mRNAs and directly examined the effects of IFN on progeny virus yield of tsG41 rather than assuming that replication of tsG41 and WT VSV was affected equally by IFN in our cell lines.
How do we reconcile the apparently contradictory conclusions of different investigators that the action of IFN against VSV is brought about by impairment of different stages of the viral life cycle? We suggest that different modes of action may operate in different cell lines and more than one such mechanism may operate in the same cell line. Support for the above line of thinking comes from what is known about the mechanism of action of IFN against influenza virus. It has been elegantly demonstrated that the IFN-inducible Mx protein inhibits influenza virus replication (33) and functions at the level of primary transcription (11) . However, influenza virus is sensitive to IFN to some degree in Mx-cells, in which this type of inhibition is at the level of viral protein synthesis (11) . In a similar manner, IFN may impair both VSV RNA synthesis and protein synthesis. In JLSV-11 cells the former mechanism was prevalent, in U cells the latter one was prevalent, and in GM2767 cells both were functional. As a consequence, VSV yield was diminished by IFN treatment of JLSV-11 and U cells by about 103-fold only, whereas in GM2767 cells it was reduced by 106-fold.
Although all actions of IFN, including its antiviral actions, are mediated by products of different IFN-inducible genes, identification of the gene responsible for a specific action has only been possible in the case of the Mx gene. We have been using partially IFN-responsive cell lines to determine whether certain IFN-inducible gene products are likely to be reponsible for specific antiviral actions of IFNs (7, (28) (29) (30) (31) . For example, we have previously shown that the 2',5'-oligoadenylate synthetase-RNase L pathway is defective in JLSV-11 cells (29) . This suggests that VSV replication can be inhibited via other IFN-inducible pathways. Similarly, the double-stranded RNA-dependent protein kinase pathway is unlikely to have a role in this function since it is not induced in IFN-treated human fibroblasts (9) . Recently we have observed that in RD-114 cells several IFN-inducible mRNAs are induced normally (J. Kusari and G. C. Sen, unpublished observation), making it highly unlikely that the products of these mRNAs are by themselves responsible for anti-VSV actions. As cDNA probes for more IFN-inducible human and mouse mRNAs become available, our partially responsive cell lines would be increasingly useful for correlating different antiviral actions with the expression of different IFN-inducible genes.
The mechanism of inhibition of VSV primary transcription in IFN-treated GM2767 and JLSV-11 cells remains to be understood. The synthesis of VSV mRNAs could be impaired directly or the degradation of these mRNAs could be enhanced in IFN-treated cells. In vitro VSV transcriptional systems would be useful for clarifying these issues. Recent observations by two groups that tubulin (22) 
